What's New
The DeGregorio Family Foundation is pleased to announce that we have awarded $250,000 in two new grants after a highly competitive grant application and selection process which included proposals from some of the nation’s most prestigious medical research institutions. For more on these grants, please read more at Our Research. Many thanks to all of our contributors for making these generous grants possible.
Congratulations to Pat Armstrong for running the 2011 NYC Marathon! Read more on Pat's story:
http://msn.foxsports.com/other/story/runner-patrick-armstrong-tackles-nyc-marathon-without-stomach-110511
http://www.nj.com/sports/njsports/index.ssf/2011/11/dalessandro_montclair_man_to_r.html
On December 19, 2011, the DeGregorio Family Foundation visited the NYSE highlighting the urgency for more funding of stomach and esophageal cancer research. In honor of the occasion, the Board of Directors of the DeGregorio Family Foundation rang the closing bell.
https://exchanges.nyx.com/en/new-york-stock-exchange/degregorio-family-foundation-nyse
The DeGregorio Family Foundation is proud to support research. In 2006, the Foundation funded the MSKCC registry to better understand the various types of stomach cancers. Read about the exciting research that was supported by the findings of the MSKCC registry. Read More
We welcome the New York Stock Exchange and the Seaport Group as corporate sponsors of the DeGregorio Family Foundation.
The Foundation recently administered its first $100,000 pilot research grant to Dr. Matthew Meyerson of the Dana Farber Cancer Institute. We hope that these annual grants for promising researchers and clinical scientists worldwide can make meaningful strides in gastric and esophageal cancer research, as we know the need for private research dollars is significant. As this fund to support high quality collaborative research grows, our Scientific Advisory Board will be able to increase the funds awarded to individual researchers. We hope to award more research grants each year.
Our Scientific Advisory Board is comprised of world renowned oncologists and scientists from institutions world wide who share the will and talent to make meaningful inroads in the advancement of research on these diseases.
Welcome New Board Members!
- Yelena Janjigian
- Lee Ellis, M.D.







